This paper is in the following e-collection/theme issue:

Grant Proposals (funded, non-ehealth) (70)

Published on in Vol 11, No 7 (2022): July

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/36780, first published .
Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study

Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study

Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study

Authors of this article:

Lakshmanan Krishnamurti1 Author Orcid Image ;   Staci D Arnold1 Author Orcid Image ;   Ann Haight1 Author Orcid Image ;   Allistair Abraham2 Author Orcid Image ;   Gregory MT Guilcher3 Author Orcid Image ;   Tami John4 Author Orcid Image ;   Nitya Bakshi1 Author Orcid Image ;   Shalini Shenoy5 Author Orcid Image ;   Karen Syrjala6 Author Orcid Image ;   Paul L Martin7 Author Orcid Image ;   Sonali Chaudhury8 Author Orcid Image ;   Gretchen Eames9 Author Orcid Image ;   Olusola Festus Olowoselu10 Author Orcid Image ;   Matthew Hsieh11 Author Orcid Image ;   Josu De La Fuente12 Author Orcid Image ;   Kimberly A Kasow13 Author Orcid Image ;   Elizabeth Stenger1 Author Orcid Image ;   Anne Mertens1 Author Orcid Image ;   Fuad El-Rassi14 Author Orcid Image ;   Peter Lane1 Author Orcid Image ;   Bronwen E Shaw15 Author Orcid Image ;   Lillian Meacham1 Author Orcid Image ;   David Archer1 Author Orcid Image
Article Authors Cited by (6) Tweetations (4) Metrics

Journals

  1. Page K, Spellman S, Logan B. Worldwide sources of data in haematology: Importance of clinician-biostatistician collaboration. Best Practice & Research Clinical Haematology 2023;36(2):101450 View
  2. Borecka O, Ofori A, Amini F, Llewellyn S. Sickle Cell Disease: A Global Patient Registry Review. Future Rare Diseases 2022;2(4) View
  3. Meacham L, George S, Veludhandi A, Pruett M, Haight A, Arnold S, Elchuri S, Stenger E, Krishnamurti L. Female Reproductive Health Outcomes after Hematopoietic Cell Transplantation for Sickle Cell Disease: Is Reduced Intensity Better Than Myeloablative Conditioning?. Transplantation and Cellular Therapy 2023;29(8):531.e1 View
  4. Vallée T, Schmid I, Gloning L, Bacova M, Ahrens J, Feuchtinger T, Klein C, Gaertner V, Albert M. Excellent outcome of stem cell transplantation for sickle cell disease. Annals of Hematology 2023;102(11):3217 View
  5. George S, Veludhandi A, Xiang Y, Liu K, Stenger E, Arnold S, Mehta A, Schirmer D, Spencer J, Guilcher G, Bhatia M, Abraham A, Gomez-Lobo V, Krishnamurti L, Meacham L. Reproductive Health Assessment and Reports of Fertility Counseling in Pediatric and Adolescent Patients with Sickle Cell Disease After Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy 2024;30(9):912.e1 View
  6. Smith W, McClish D, Valrie C, Sisler I. What interval of daily pain assessment is required to reliably diagnose chronic pain in SCD? The Pain in Sickle Cell Epidemiology Study. Journal of Sickle Cell Disease 2024;1(1) View